Sangamo Therapeutics Stock Technical Analysis
SGMO Stock | USD 2.36 0.10 4.42% |
As of the 3rd of December, Sangamo Therapeutics has the Semi Deviation of 4.54, coefficient of variation of 476.8, and Risk Adjusted Performance of 0.1694. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sangamo Therapeutics, as well as the relationship between them.
Sangamo Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Sangamo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to SangamoSangamo |
Sangamo Therapeutics Analyst Consensus
Target Price | Advice | # of Analysts | |
6.58 | Buy | 8 | Odds |
Most Sangamo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Sangamo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Sangamo Therapeutics, talking to its executives and customers, or listening to Sangamo conference calls.
Sangamo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Sangamo Therapeutics Technical Analysis
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Sangamo Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Sangamo Therapeutics Trend Analysis
Use this graph to draw trend lines for Sangamo Therapeutics. You can use it to identify possible trend reversals for Sangamo Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Sangamo Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Sangamo Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Sangamo Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.03 , which means Sangamo Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 39.89, which is the sum of squared deviations for the predicted Sangamo Therapeutics price change compared to its average price change.About Sangamo Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Sangamo Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Sangamo Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Sangamo Therapeutics price pattern first instead of the macroeconomic environment surrounding Sangamo Therapeutics. By analyzing Sangamo Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Sangamo Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Sangamo Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 20.98 | 14.67 | 2.75 | 2.61 | PTB Ratio | 2.89 | 1.64 | 1.14 | 1.09 |
Sangamo Therapeutics December 3, 2024 Technical Indicators
Most technical analysis of Sangamo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sangamo from various momentum indicators to cycle indicators. When you analyze Sangamo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.1694 | |||
Market Risk Adjusted Performance | 0.5351 | |||
Mean Deviation | 6.47 | |||
Semi Deviation | 4.54 | |||
Downside Deviation | 5.46 | |||
Coefficient Of Variation | 476.8 | |||
Standard Deviation | 9.52 | |||
Variance | 90.64 | |||
Information Ratio | 0.1967 | |||
Jensen Alpha | 1.55 | |||
Total Risk Alpha | 0.5627 | |||
Sortino Ratio | 0.3432 | |||
Treynor Ratio | 0.5251 | |||
Maximum Drawdown | 50.57 | |||
Value At Risk | (7.53) | |||
Potential Upside | 24.14 | |||
Downside Variance | 29.77 | |||
Semi Variance | 20.62 | |||
Expected Short fall | (8.64) | |||
Skewness | 1.73 | |||
Kurtosis | 3.67 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sangamo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sangamo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.24) | Revenue Per Share 0.066 | Quarterly Revenue Growth (0.95) | Return On Assets (0.58) | Return On Equity (1.94) |
The market value of Sangamo Therapeutics is measured differently than its book value, which is the value of Sangamo that is recorded on the company's balance sheet. Investors also form their own opinion of Sangamo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sangamo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sangamo Therapeutics' market value can be influenced by many factors that don't directly affect Sangamo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.